Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jupiter Neurosciences (JUNS) Research & Development (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Research & Development for 2 consecutive years, with $43684.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 78.27% to $43684.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 323.53% year-over-year, with the annual reading at $2.1 million for FY2025, 323.53% up from the prior year.
  • Research & Development for Q4 2025 was $43684.0 at Jupiter Neurosciences, down from $816697.0 in the prior quarter.
  • The five-year high for Research & Development was $816697.0 in Q3 2025, with the low at $43684.0 in Q4 2025.